01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

More documents

Recommendations

Info

al (1996) Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes 45, 679-682. Magovern CJ, Mack CA, Zhang J, Rosengart TK, Isom OW, Crystal RG (1997) Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. Hum Gene Ther 8, 215- 227. Maher J, Colonna F, Baker D, Luzzatto L, Roberts I (1994) Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation. Exp Hematol 22, 8-12. Maher LJ 3d, Dervan PB, Wold B (1992) Analysis of promoterspecific repression by triple-helical DNA complexes in a eukaryotic cell-free transcription system. Biochemistry 31, 70-81. Mahvi DM, Burkholder JK, Turner J, Culp J, Malter JS, Sondel PM, Yang NS (1996) Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. Hum Gene Ther 7, 1535-1543. Mahvi DM, Sondel PM, Yang NS, Albertini MR, Schiller JH, Hank J, Heiner J, Gan J, Swain W, Logrono R (1997) Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma. Hum Gene Ther 8, 875-891. Maillard L and Walsh K (1996) Growth-arrest homeobox gene Gax: a molecular strategy to prevent arterial restenosis. Schweiz Med Wochenschr 126, 1721-1726. Makarov SS, Olsen JC, Johnston WN, Anderle SK, Brown RR, Baldwin AS Jr, Haskill JS, Schwab JH (1996) Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci USA 93, 402-406. Malik P, McQuiston SA, Yu XJ, Pepper KA, Krall WJ, Podsakoff GM, Kurtzman GJ, Kohn DB (1997) Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J Virol 71, 1776-1783. Malim MH, Böhnlein S, Hauber J, Cullen BR (1989) Functional dissection of the HIV-1 Rev trans-activator--Derivation of a trans-dominant repressor of Rev function. Cell 58, 205-214. Malosky S, Kolansky DM (1996) Gene therapy for ischemic heart disease. Curr Opin Cardiol 11, 361-368. Mamounas M, Leavitt M, Yu M, Wong-Staal F (1995) Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes. Gene Ther 2, 429-432. Mancini MA, Shan B, Nickerson JA, Penman S, Lee WH (1994) The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc Natl Acad Sci USA 91, 418-422. Mandel RJ, Spratt SK, Snyder RO, Leff SE (1997) Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci USA 94, 14083-14088. Boulikas: An overview on gene therapy 148 Manome Y, Wen PY, Dong Y, Tanaka T, Mitchell BS, Kufe DW, Fine HA (1995) Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nature Med 2, 567-573. Marie J-P, Zittoun R and Sikic BI (1991) Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 78, 586-592. Mariman, E.C.M, van Eekelen, C.A.G., Reinders, R.J., Berns, A.J.M. and van Venrooij, W.J. (1982) Adenoviral heterogeneous nuclear RNA is associated with the host nuclear matrix during splicing. J Mol Biol 154, 103. Marini III FC, Cannon JP, Belmont JW, Shillitoe EJ, LaPeyre J- N (1995) In vivo marking of spontaneous or vaccine-induced fibrosarcomas in the domestic house cat, using an adenoviral vector containing a bifunctional fusion protein, GAL-TEK. Hum Gene Ther 6, 1215-1223. Markowitz D, Hesdorffer C, Ward M, Goff S, Bank A (1990) Retroviral gene transfer using safe and efficient packaging cell lines. Ann N Y Acad Sci 612, 407-414. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, et al (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338. Martin F and Boulikas T (1998) The challenge of liposomes in gene therapy. Gene Ther Mol Biol 1, 173-214. Martin PA (1997) Editorial: Bridging the “commercialization gap” in Europe. Gene Ther 4, 881-882. Martin SJ and Green DR (1995) Protease activation during apoptosis: death by a thousand cuts? Cell 82, 349-352. Mayordomo, JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med 1, 1297-1302. Maze R, Hanenberg H, Williams DA (1997) Establishing chemoresistance in hematopoietic progenitor cells. Mol Med Today 3, 350-358. McDonald RJ, Lukason MJ, Raabe OG, Canfield DR, Burr EA, Kaplan JM, Wadsworth SC, St George JA (1997) Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primate. Hum Gene Ther 8, 411-422. McKnight, R.A., Shamay, A., Sankaran, L., Wall, R.J., and Hennighausen, L. (1992) Matrix-attacment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc. Natl. Acad. Sci. 89, 6943- 6947. Mercer WE, Shields MT, Lin D, Appella, Ullrich SJ (1991) Growth supprssion induced by wild-type p53 protein is accompanied by selective down-regulation of proliferatingcell nuclear antigen expression. Proc Natl Acad Sci USA 88, 1958-1962. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, and Hall PA (1994) The role of p53 in spontaneous and
adiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 54, 614-617. Mesri EA, Federoff HJ, Brownlee M (1995) Expression of vascular endothelial growth factor from a defective herpes simplex virus type 1 amplicon vector induces angiogenesis in mice. Circ Res 76, 161-167. Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA (1997) Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-κB antagonists. J Virol 71, 6486-6494. Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG (1995) DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 92, 5307-5311 Midoux P, Mendes C, Legrand A, Raimond J, Mayer R, Monsigny M, Roche AC (1993) Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res 21, 871-878. Migita M, Medin JA, Pawliuk R, Jacobson S, Nagle JW, Anderson S, Amiri M, Humphries RK, Karlsson S (1995) Selection of transduced CD34 + progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors. Proc Natl Acad Sci USA 92, 12075-12079. Mihara, K., Cao, X.-R., Yen, A., Chandler, S., Driscoll, B., Murphree, A.L., T'ang, A. and Fung, Y.-K.T. (1989) Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246, 1300-1303. Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Møller NPH, Risau W, and Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846. Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10, 4239- 4242. Miller SD, Farmer G, Prives C (1995) p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner. Mol Cell Biol 15, 6554-6560. Mirkin SM, Lyamichev VI, Drushlyak KN, Dobrynin VN, Filippov SA, Frank-Kamenetskii MD (1987) DNA H form requires a homopurine-homopyrimidine mirror repeat. Nature 330, 495-497. Mitchell PJ and Tjian R (1989) Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245, 371-378 Miura M, Zhu H, Rotello R, Hartwieg EA, and Huan J (1993) Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660. Miyake K, Tohyama T, Shimada T (1996) Two-step gene transfer using an adenoviral vector carrying the CD4 gene and human immunodeficiency viral vectors. Hum Gene Ther 7, 2281-2286. Miyanohara A, Sharkey MF, Witztum JL, Steinberg D, Friedmann T (1988) Efficient expression of retroviral vector- Gene Therapy and Molecular Biology Vol 1, page 149 149 transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro. Proc Natl Acad Sci USA 85, 6538-6542. Miyashita T , Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299. Miyashita T, Harigai M, Hanada M, Reed JC (1994b) Identification of p53-dependent negative response element in the bcl-2 gene. Cancer Res 54, 3131-3135. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994a) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805. Miyatake S, Martuza RL, Rabkin SD (1997) Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma. Cancer Gene Ther 4, 222- 228. Miyoshi H, Takahashi M, Gage FH, Verma IM (1997) Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA 94, 10319-10323. Moelling K (1997) DNA for genetic vaccination and therapy. Cytokines Cell Mol Ther 3, 127-135. Moffatt M, Cookson W (1995) Naked DNA: New shots for allergy? Nature Med 2, 515-516. Mogayzel PJ Jr, Henning KA, Bittner ML, Novotny EA, Schwiebert EM, Guggino WB, Jiang Y, Rosenfeld MA (1997) Functional human CFTR produced by stable Chinese hamster ovary cell lines derived using yeast artificial chromosomes. Hum Mol Genet 6, 59-68. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245. Momparler RL, Eliopoulos N, Bovenzi V, Letourneau S, Greenbaum M, Cournoyer D (1996) Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells. Cancer Gene Ther 3, 331-338. Moolten FL (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 46, 5276- 5281. Moolten FL, Wells JM (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82, 297-300. Morgan JR, Barrandon Y, Green H, Mulligan RC (1987) Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237, 1476- 1479. Morgenstern JP and Land H (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18, 3587-3596. Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ (1994) Intimal hyperplasia after vascular injury is inhibited by
Page 1 and 2:
Gene Ther Mol Biol Vol 1, 1-172. Ma
Page 3 and 4:
I. Introduction Monumental progress
Page 5 and 6:
The use of retroviral vectors in hu
Page 7 and 8:
displaying the cleavable EGF domain
Page 9 and 10:
molecules in the nucleus (Lowe and
Page 11 and 12:
sensitive mutations which allow pro
Page 13 and 14:
processed as described in panel A s
Page 15 and 16:
On the contrary, the payload capaci
Page 17 and 18:
in K562 human erythroleukemia cells
Page 19 and 20:
defective HSV virus (DeLuca and Sch
Page 21 and 22:
complex into the cytosol from the e
Page 23 and 24:
Gene Therapy and Molecular Biology
Page 25 and 26:
delivered by Sendai virus-liposome
Page 27 and 28:
plasmids with the cell surface, tra
Page 29 and 30:
infected by adenovirus alone; infec
Page 31 and 32:
Page 33 and 34:
B. Transcription factor binding sit
Page 35 and 36:
A closely related family of ubiquit
Page 37 and 38:
cells. I-CreI is a member of this c
Page 39 and 40:
Page 41 and 42:
C. Considerations of chromatin stru
Page 43 and 44:
Page 45 and 46:
A. The molecular basis of cancer im
Page 47 and 48:
fragments, or heat shock proteins c
Page 49 and 50:
ecombinant vaccinia virus expressin
Page 51 and 52:
HIV-1 envelope DNA construct develo
Page 53 and 54:
inding sites A GYYY oriented in opp
Page 55 and 56:
Page 57 and 58:
Prives, 1994). Whereas the wild-typ
Page 59 and 60:
mutant p53 (mutations on p53 are wi
Page 61 and 62:
master regulator of the cell cycle
Page 63 and 64:
Work from several groups has shown
Page 65 and 66:
chromatin condensation, drop in pH,
Page 67 and 68:
Figure 23. A pathway leading to the
Page 69 and 70:
Excessive necrotic death in cells o
Page 71 and 72:
implantation, and similar processes
Page 73 and 74:
normal cells in the surroundings. T
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
A bicistronic retroviral vector (Ha
Page 81 and 82:
C. Antisense ras gene transfer for
Page 83 and 84:
equal to 6.0 showed S1 hyperreactiv
Page 85 and 86:
protein (e.g. Smith et al, 1995; Fo
Page 87 and 88:
transduced primary mouse fibroblast
Page 89 and 90:
IL-1 - receptor antagonist protein
Page 91 and 92:
p53 lung cancer retroviru s MHC cla
Page 93 and 94:
Page 95 and 96:
designed by immunization with porti
Page 97 and 98: Isolation of an RNA aptamer that ca
Page 99 and 100: induction of human apoE in neonate
Page 101 and 102: atrium in heart, endothelial cells
Page 103 and 104: which eliminated tumors in small an
Page 105 and 106: C. Transfer of other genes against
Page 107 and 108: Gene Therapy and Molecular Biology
Page 109 and 110: significant reduction in neointima
Page 111 and 112: (Prehn et al, 1996); this implies a
Page 113 and 114: B. Approaches to gene therapy of RA
Page 115 and 116: of human immunoglobulin and antigen
Page 117 and 118: A. Etiology and mechanisms of destr
Page 121 and 122: However, CsA also inhibits the acti
Page 123 and 124: The peptide kinin, after binding to
Page 125 and 126: intake when administered to adrenal
Page 127 and 128: Introgen Therapeutics (Austin and H
Page 129 and 130: When a subfragment of only 513 bp o
Page 131 and 132: Armentano D, Zabner J, Sacks C, Soo
Page 133 and 134: Brady HJM, Miles CG, Pennington DJ,
Page 135 and 136: Chen J, Stickles RJ, Daichendt KA (
Page 137 and 138: Day ML, Wu S, Basler JW (1993) Pros
Page 139 and 140: Farmer G, Bargonetti J, Zhu H, Frie
Page 141 and 142: Giovannangeli C, Perrouault L, Escu
Page 143 and 144: the neoplastic phenotype by replace
Page 145 and 146: integrate in a site-specific fashio
Page 147: Li R, Waga S, Hannon GJ, Beach D, S
Page 151 and 152: Nakaya T, Iwai S, Fujinaga K, Sato
Page 153 and 154: Polyak K, Xia Y, Zweier JL, Kinzler
Page 155 and 156: macrophages from simian immunodefic
Page 157 and 158: intimal hyperplasia in a rat caroti
Page 159 and 160: Trono D, Feinberg MB, Baltimore D (
Page 161 and 162: Wattiaux R, Jadot M, Warnier-Pirott
Page 163 and 164: similar to mammalian interleukin-1
Page 167 and 168: 24. Gene Marking /Infectious Diseas
Page 169 and 170: Drug 50. Gene Therapy /Phase I /Can
Page 171 and 172: 76. Gene Therapy /Phase I /Cancer /
Page 173 and 174: 99. Gene Therapy /Phase II /Cancer
Page 175 and 176: 120. Gene Therapy /Phase I /Monogen
Page 179 and 180: cancer not specified) /Immunotherap
show all

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Create successful ePaper yourself

Delete template?

Save as template?